Collectively, these results allow for a conclusion that regional metabolic heterogeneity in glioblastoma leads to low GLS2 expression and low levels of NADPH and GSH levels in the malignant area, while high GLS2 expression, together with high levels of NADPH and GSH, is found in the lower grade area [114]. This evidence concerns the gene GLS2 and glioblastoma.